Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users

Published:2021-10-28 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Shram Megan J.¹,Spencer Robert H.²,Qian Jenny²,Munera Catherine L.²,Lewis Michael E.³,Henningfield Jack E.⁴,Webster Lynn⁵,Menzaghi Frédérique²

Affiliation:

1. Altreos Research Partners, Inc. Toronto ON Canada

2. Cara Therapeutics, Inc. Stamford Connecticut USA

3. BioDiligence Partners, Inc. Kennett Square Pennsylvania USA

4. Pinney Associates Bethesda Maryland USA

5. PRA Health Sciences Salt Lake City Utah USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13173

Reference41 articles.

1. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?

2. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus

3. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients

4. Psychotomimesis Mediated by κ Opiate Receptors

5. Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain;Pande AC;Clin Neuropharmacol,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials;Renal Failure;2024-08

2. Long-term efficacy and safety of difelikefalin in moderate-to-severe pruritus in Japanese hemodialysis patients: a 52-week open-label extension period of a phase 3 trial;Renal Replacement Therapy;2024-07-19

3. Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis;Nephrology Dialysis Transplantation;2023-11-15

4. Endogenous opiates and behavior: 2022;Peptides;2023-11

5. Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study;Frontiers in Pharmacology;2023-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3